Roy Avraham Hilzenrat

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 7

Top Topics

Replacement Therapy

Prognostic Factors

Ejection Fraction

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)
Roy Avraham Hilzenrat, Stephen Yip, Barbara L Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J Choi, Anna L McGuire
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current oncology (Toronto, Ont.) 30 (1) (2022)